Key facts
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for Axon Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Axon Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axon Diagnostics
Operator of diagnostic platforms and provider of diagnostic services intended to improve the working lives of clinicians and support better diagnostic care for all. The company offers regional radiology insourcing, teleradiology, audit, home reporting, digital pathology, PACS as a service, and more, enabling clinicians to improve efficiency in the delivery of diagnostics.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 25
- Website
- axondiagnostics.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Axon Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axon Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axon Diagnostics in its N-PORT filings yet. We sweep new filings monthly.